Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Antennova to Present Latest Data of ATN-037 in a Mini Oral Presentation at ESMO Congress 2024 2024-09-09 08:30
ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress 2024-09-09 08:25
Sciwind Biosciences Announces Oral Presentations at the European Association for the Study of Diabetes 60th Annual Meeting (EASD 2024) 2024-09-06 10:10
Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation 2024-09-05 20:00
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration 2024-09-05 13:49
Chugai Pharma Taiwan wins Social Empowerment and Green Leadership Categories at the Asia Responsible Enterprise Awards 2024 2024-09-05 10:47
Veeva Vault CRM Suite to Unlock Greater Customer Centricity with Launch of Service Center 2024-09-05 09:00
Grand launch | Sanyou Bio monkeypox antibody made a great breakthrough 2024-09-05 08:00
TraceLink's Magnum Release of its Opus Platform Will Revolutionize Supply Chain Management by Enabling All Businesses to Digitalize their End-to-End Supply Networks 2024-09-04 22:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
HKBU develops Chinese medicine for ulcerative colitis approved by National Medical Products Administration for clinical trial 2024-09-04 15:13
Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma 2024-09-04 08:00
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances 2024-09-04 06:57
Biostar Announces Completion of Patient Recruitment for US Phase 1 Clinical Study of Utidelone Capsule 2024-09-03 20:00
Skyline Therapeutics' Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosa 2024-09-03 18:00
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA 2024-09-03 15:59
Caliway Announces the Initiation of Subject Recruitment in CBL-514 Phase 2b Study for Dercum's Disease 2024-09-03 15:18
Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays 2024-09-02 21:00
Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor 2024-09-02 20:24
1 26 27 28 29 30 423